Vivek Dhariwal, is the Chairman and Non-Executive Independent Director of the Company. He holds a bachelor’s degree in technology (chemical engineering)from the Indian Institute of Technology, Bombay, and a master’s degree in science (chemical engineering) from the University of Kentucky. He has over 20 years of experience in manufacturing and supply operations. He was previously associated with ICI India Limited, Baxter India Private Limited, and Pfizer Limited. Ashok Kumar Windlass, is the whole-time Director of the Company. He holds a diploma in civil engineering from Government Polytechnic, Ambala City. He has over 20years of experience in the manufacturing and pharmaceutical business in India. He is one of the Promoters and one of the founders of the Company. He is one of the first directors of the Company and was appointed as the Managing Director of the company on April 1, 2001, and subsequently appointed as the Wholetime Director on May 3, 2021. He plays a significant role in the administration, legal and engineering functions of the Company. He is also the Chairman of the confederation of Indian Industries Uttarakhand StateCouncil. Hitesh Windlass, is the Managing Director of the Company. He holds a bachelor’s degree in ceramic engineering from the Indian Institute of Technology, Banaras Hindu University, and a master’s degree in business administration from the Graduate School of Business, University of Chicago. He has set up our Domestic Trade Generics, OTC Brands, and Exports SBVs and plays a significant role in driving the technical operations, quality, R&D, manufacturing strategy, and financial strategy of our Company. He has over 13 years of experience in the field of management. He was previously associated as a process engineer with Intel Corporation, USA. He joined the Company on January 21, 2008, as Director and was appointed as Managing Director of the Company on April 30, 2020. Manoj Kumar Windlass, is the Joint Managing Director of the Company. He holds a bachelor’s degree in business administration from Georgia State University, Atlanta. He has over 15 years of experience in product development, operations, procurement, and portfolio functions of the medicine business. He has set up our CDMO Services and Products SBV and plays a significant role in driving the product portfolio decisions and overall commercial operations including business development, supply chain, and procurement of the Company. He joined the Company on April 1, 2006as a Director of the Company and was appointed as Joint Managing Director of the Company on April 30, 2020.

 

Particulars (Millions)	Mar 21	Mar 20	Mar 19
Revenue	4,276	3288	3072
Cost of material consumed	2707	2243	1882
Change in inventories	36	-127	36
Employee Benefit Expenses	583	435	429
Other Expenses	401	322	338
Operating Profit	549	415	387
OPM %	12.84%	12.62%	12.60%
Other Income	30	24	42
Depreciation & Amortisations	129	92	105
Financial Cost	13	25	48
Exceptional Profit	0	0	495
Profit Before Tax	217	246	761
Net Profit	156	160	637
NPM%	3.65%	4.87%	20.74%
EPS	8.7	8.9	37.65

 

There are no listed companies in India that engage in a business similar to that of the Company.

Review and Recommendation of Windlas Biotech IPO from InvestorZone is 4/10 1. Company has good products in the market and good client base. 2. The company has shown good growth in the top-line however same is not reflected in the bottomline. 3. The issue looks stretched at P/E of 64x. Having said that, the bull market is going on and all these IPOs can be played for listing gain.

40/1,Mohabewala Industrial Area, Dehradun248 110, Uttarakhand, India Tel:+91 135 6608000